State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.
State Key Laboratory of Quality Research in Chinses Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa university boulevard, Macau, People's Republic of China.
Pharmacol Res. 2020 Sep;159:104919. doi: 10.1016/j.phrs.2020.104919. Epub 2020 May 25.
Ferroptosis is a new kind of regulated cell death that is characterized by highly iron-dependent lipid peroxidation. Ferroptosis involves various biology processes, such as iron metabolism, lipid metabolism, oxidative stress and biosynthesis of nicotinamide adenine dinucleotide phosphate (NADPH), glutathione (GSH) and coenzyme Q10 (CoQ10). A growing body of evidence suggests that ferroptosis is associated with cancer and neurodegenerative diseases (Alzheimer's disease, Parkinson's disease and Huntington's disease). This finding has helped develop a novel cytoprotective strategy to protect cells in neurodegenerative, blood and heart diseases by inhibiting ferroptosis. Meanwhile, the selective induction of ferroptosis has been adopted as a potential treatment strategy in some kinds of cancer. This review aims to summarize the mechanism of ferroptosis regulation and relevance to pathological physiology.
铁死亡是一种新的受调控的细胞死亡方式,其特征是高度依赖铁的脂质过氧化。铁死亡涉及多种生物学过程,如铁代谢、脂质代谢、氧化应激以及烟酰胺腺嘌呤二核苷酸磷酸(NADPH)、谷胱甘肽(GSH)和辅酶 Q10(CoQ10)的生物合成。越来越多的证据表明,铁死亡与癌症和神经退行性疾病(阿尔茨海默病、帕金森病和亨廷顿病)有关。这一发现有助于开发一种新的细胞保护策略,通过抑制铁死亡来保护神经退行性、血液和心脏疾病中的细胞。同时,选择性诱导铁死亡已被用作某些癌症的潜在治疗策略。本综述旨在总结铁死亡调控的机制及其与病理生理学的相关性。